Investor Presentaiton
2Q15 Highlights
■Net revenues reached $336.8 million, up from $334.5 million a year ago.
■China net revenues grew 0.9% year-over-year to $153.9 million, representing
45.7% of the company's total net revenues.
■International net revenues were $183.0 million, compared to $182.0 million in the
second quarter of 2014. Sale in Africa achieved close to 30% year-over-year
growth.
Reagent net revenues increased more than 20% year-over-year. Reagents led the
IVD segment growth and contributed 48.8% to the IVD segment, up from 42.9% in
the same period last year.
■Launched four products during the quarter, including a mid-end biochemistry
analyzer, a mid-to-low end hematology analyzer, a mid-end
glycohemoglobin analyzer, and a mid-to-low-end color ultrasound.
12
mindrayView entire presentation